Concr

company

About

Solving data to enable precision diagnostics for all.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
£499.84K
Industries
Biotechnology,Machine Learning
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Concr is an emerging software platform to combat cancer. It combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment.

This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine.
Concr aims to:

• Reduce treatment resistance
• Cut the cost of cancer treatment
• Enable proactive treatment adaptation
• Save lives

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£499.84K
Concr has raised a total of £499.84K in funding over 2 rounds. Their latest funding was raised on Apr 1, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 1, 2021 Seed £499.84K 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Concr is funded by 2 investors. Accelerate@Babraham and KQ Labs are the most recent investors.
Investor Name Lead Investor Funding Round
Accelerate@Babraham Seed
KQ Labs Seed